Eligibility Metastatic Breast Cancer NCT01423695

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed metastatic breast cancer overexpressing her2
Beschrijving

metastatic breast cancer

Datatype

boolean

Alias
UMLS CUI [1,1]
C1960398
UMLS CUI [1,2]
C0027627
pretreatment with anthracycline in either the adjuvant or palliative setting.
Beschrijving

anthracycline

Datatype

boolean

Alias
UMLS CUI [1]
C0003234
her2 positivity was defined as 2+ or 3+ overexpression using the dako herceptest, confirmed by fluorescence in-situ hybridization (fish) if 2+.
Beschrijving

her2 positivity

Datatype

boolean

Alias
UMLS CUI [1]
C4031572
informed consent
Beschrijving

informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
more than 1 chemotherapy for advanced disease
Beschrijving

chemotherapy

Datatype

boolean

Alias
UMLS CUI [1]
C0392920
taxane or trastuzumab pretreatment
Beschrijving

taxane or trastuzumab

Datatype

boolean

Alias
UMLS CUI [1]
C0215136
UMLS CUI [2]
C0728747
brain metastases
Beschrijving

brain metastases

Datatype

boolean

Alias
UMLS CUI [1]
C0220650
eastern cooperative oncology group (ecog) performance status >1
Beschrijving

performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
pregnancy or lactation, childbearing potential without reliable contraception
Beschrijving

pregnancy or lactation

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
clinically significant cardiac disease,
Beschrijving

cardiac disease

Datatype

boolean

Alias
UMLS CUI [1]
C0018799
neutrophils <1500/µl, platelets <75,000/µl
Beschrijving

neutrophils platelets

Datatype

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0005821
total bilirubin and creatinine >1.5 × the upper limit of normal
Beschrijving

total bilirubin and creatinine

Datatype

boolean

Alias
UMLS CUI [1]
C0201913
UMLS CUI [2]
C0201976

Similar models

Eligibility Metastatic Breast Cancer NCT01423695

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
metastatic breast cancer
Item
histologically confirmed metastatic breast cancer overexpressing her2
boolean
C1960398 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
anthracycline
Item
pretreatment with anthracycline in either the adjuvant or palliative setting.
boolean
C0003234 (UMLS CUI [1])
her2 positivity
Item
her2 positivity was defined as 2+ or 3+ overexpression using the dako herceptest, confirmed by fluorescence in-situ hybridization (fish) if 2+.
boolean
C4031572 (UMLS CUI [1])
informed consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
chemotherapy
Item
more than 1 chemotherapy for advanced disease
boolean
C0392920 (UMLS CUI [1])
taxane or trastuzumab
Item
taxane or trastuzumab pretreatment
boolean
C0215136 (UMLS CUI [1])
C0728747 (UMLS CUI [2])
brain metastases
Item
brain metastases
boolean
C0220650 (UMLS CUI [1])
performance status
Item
eastern cooperative oncology group (ecog) performance status >1
boolean
C1520224 (UMLS CUI [1])
pregnancy or lactation
Item
pregnancy or lactation, childbearing potential without reliable contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
cardiac disease
Item
clinically significant cardiac disease,
boolean
C0018799 (UMLS CUI [1])
neutrophils platelets
Item
neutrophils <1500/µl, platelets <75,000/µl
boolean
C0948762 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
total bilirubin and creatinine
Item
total bilirubin and creatinine >1.5 × the upper limit of normal
boolean
C0201913 (UMLS CUI [1])
C0201976 (UMLS CUI [2])